C Adithan
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Pharmacology 20
- Pharmacogenetics and Drug Metabolism 17
- Co-authors
- Sandhiya Selvarajan (3 shared papers)Suresh Chandra Pradhan (2 shared papers)C. H. Shashindran (9 shared papers)Pravati Pal (7 shared papers)R. V. Krishnamoorthy (3 shared papers)G K Pal (6 shared papers)Nathalie Gérard (3 shared papers)Nivedita Nanda (5 shared papers)
In The Last Decade
C Adithan
70 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 122
- Pharmacology 309
- Toxicology 95
- Geriatrics and Gerontology 51
- Endocrinology, Diabetes and Metabolism 178
- Pediatrics, Perinatology and Child Health 194
Countries citing papers authored by C Adithan
This map shows the geographic impact of C Adithan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Adithan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Adithan more than expected).
Fields of papers citing papers by C Adithan
This network shows the impact of papers produced by C Adithan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Adithan. The network helps show where C Adithan may publish in the future.
Co-authors
The 25 scholars most cited alongside C Adithan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel applications of nanotechnology in medicine. | 2009 | 112 |
| 2 | 2007 | 107 | |
| 3 | 2011 | 73 | |
| 4 | 2003 | 52 | |
| 5 | 2010 | 51 | |
| 6 | 2011 | 48 | |
| 7 | 2004 | 44 | |
| 8 | 2007 | 44 | |
| 9 | Influence of the CYP2C9 AND CYP2C19 polymorphisms on phenytoin hydroxylation in healthy individuals from south India. | 2006 | 36 |
| 10 | 2011 | 33 | |
| 11 | 2011 | 28 | |
| 12 | 2006 | 27 | |
| 13 | 2005 | 27 | |
| 14 | 2019 | 26 | |
| 15 | 2016 | 22 | |
| 16 | 2009 | 22 | |
| 17 | Association of aldosterone synthase (CYP11B2 C-344T) gene polymorphism & susceptibility to essential hypertension in a south Indian Tamil population. | 2010 | 22 |
| 18 | Genetic polymorphisms of CYP2E1 and GSTP1 in a South Indian population--comparison with North Indians, Caucasians and Chinese. | 2005 | 22 |
| 19 | 2008 | 21 | |
| 20 | 2016 | 20 |
About C Adithan
C Adithan is a scholar working on Pharmacology, Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery and Pharmacology, having authored 74 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (17 papers), Heart Rate Variability and Autonomic Control (7 papers), Pharmacological Effects and Toxicity Studies (7 papers), Pharmaceutical studies and practices (5 papers), Blood Pressure and Hypertension Studies (5 papers), Epilepsy research and treatment (5 papers), Hormonal Regulation and Hypertension (5 papers) and Lipoproteins and Cardiovascular Health (5 papers). The work is most often cited by research in Pharmacology (309 citations), Toxicology (95 citations), Geriatrics and Gerontology (51 citations), Endocrinology, Diabetes and Metabolism (178 citations) and Pediatrics, Perinatology and Child Health (194 citations). C Adithan has collaborated with scholars based in India, France and Germany. Frequent co-authors include Sandhiya Selvarajan, Suresh Chandra Pradhan, C. H. Shashindran, Pravati Pal, R. V. Krishnamoorthy, G K Pal, Nathalie Gérard, Nivedita Nanda, S. Gopalakrishnan and Tarun Kumar Dutta. Their work appears in journals such as European Journal of Clinical Pharmacology, Pharmacogenomics, Clinica Chimica Acta, Clinical and Experimental Hypertension and Current Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.